Epidemic

While most of us have been staying inside for several weeks, many leave the safety of their homes every day to help us live our lives as normally as possible.

I am not an expert on the phenomenon of death. But like all of us, I have to live in its shadow, and watch the restlessness and greed it causes. The same gloomy reports that circle the planet also reach me. I feel especially conscious of this as COVID-19 claims its first victims in my country.

They live in five European countries and could not be more different in age, interest or inclination. However, that made no difference. They were all infected. Some were not scared. Others were terrified. They have all gone through an experience that, without exception, has marked their lives.

Noemina is a graduate of the University of Hertfordshire, UK, where she majored in health care. She is working in her field as of 2012. The journal excerpt she sent to us reflects her week-long experience at the epicentre of the battle with the new coronavirus in the intensive care unit, where serious cases are admitted.

In mid-April 2014, the words 'scandal', 'secret', 'drugs', and 'Roche' (the Swiss drug giant) delighted the medical press, which was quick to publish tantalizing news about the ineffectiveness of Tamiflu and the enormous amounts spent by governments in order to stock up on the drug, in preparation for possible flu epidemics.